Ming Zhou Selected Research

GP 4 (GP4)

1/2021	The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
1/2019	Prostate Cancers Detected by Magnetic Resonance Imaging-Targeted Biopsies Have a Higher Percentage of Gleason Pattern 4 Component and Are Less Likely to Be Upgraded in Radical Prostatectomies.
2/2018	The Use of Magnetic Resonance Imaging to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer.
10/2015	Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations.
8/2014	Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming Zhou Research Topics

Disease

237	Neoplasms (Cancer) 11/2022 - 07/2002
50	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2002
44	Nasopharyngeal Carcinoma 01/2022 - 01/2000
42	Infections 06/2022 - 08/2005
40	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 04/2002
31	Carcinoma (Carcinomatosis) 10/2022 - 07/2003
29	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2010
28	Carcinogenesis 01/2022 - 07/2003
26	Renal Cell Carcinoma (Grawitz Tumor) 10/2022 - 07/2002
24	Inflammation (Inflammations) 03/2022 - 02/2002
21	Rabies (Hydrophobia) 01/2022 - 01/2013
12	Aplastic Anemia (Anemia, Hypoplastic) 12/2022 - 07/2017
11	Type 2 Diabetes Mellitus (MODY) 03/2019 - 01/2015
10	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2016
9	Body Weight (Weight, Body) 12/2021 - 06/2012
9	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2003
8	Adenocarcinoma 10/2022 - 03/2006
8	Obesity 01/2021 - 08/2005
8	Melanoma (Melanoma, Malignant) 10/2020 - 07/2002
8	Kidney Neoplasms (Kidney Cancer) 01/2016 - 11/2005
7	COVID-19 09/2022 - 01/2020
7	Glioma (Gliomas) 01/2022 - 10/2007
6	Prostatic Intraepithelial Neoplasia 10/2022 - 04/2002
6	Epstein-Barr Virus Infections 10/2021 - 05/2006
6	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 10/2011
6	Colorectal Neoplasms (Colorectal Cancer) 04/2020 - 09/2002
6	Parkinson Disease (Parkinson's Disease) 10/2017 - 08/2009
5	Wounds and Injuries (Trauma) 06/2022 - 11/2011
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2018
5	Hypertension (High Blood Pressure) 12/2021 - 11/2015
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2015
5	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 04/2012
5	Adenocarcinoma of Lung 11/2020 - 01/2019
5	Lymphatic Metastasis 04/2017 - 03/2006
4	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2022 - 12/2016
4	Acute Lung Injury 03/2022 - 04/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2009

Drug/Important Bio-Agent (IBA)

79	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
43	Biomarkers (Surrogate Marker)IBA 10/2022 - 04/2002
35	Long Noncoding RNAIBA 01/2022 - 01/2014
30	Messenger RNA (mRNA)IBA 01/2022 - 04/2002
27	Biological ProductsIBA 01/2022 - 12/2004
19	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2010
16	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2006
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2015
13	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2002
13	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2010
12	EnzymesIBA 01/2022 - 07/2004
12	VaccinesIBA 11/2021 - 02/2009
11	Keratins (Keratin)IBA 01/2017 - 09/2002
10	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2011
10	CytokinesIBA 01/2021 - 05/2005
10	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 08/2007
10	Complementary DNA (cDNA)IBA 08/2015 - 01/2000
9	Pharmaceutical PreparationsIBA 02/2022 - 09/2009
9	Hormones (Hormone)IBA 01/2020 - 09/2002
8	Circular RNAIBA 01/2022 - 01/2017
8	Phosphotransferases (Kinase)IBA 01/2022 - 02/2010
8	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2016
8	ParaffinIBA 01/2021 - 07/2003
7	Peptides (Polypeptides)IBA 03/2022 - 10/2013
7	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2008
7	AntibodiesIBA 01/2020 - 03/2003
6	trans-sodium crocetinate (crocetin)IBA 10/2022 - 02/2009
6	Competitive Endogenous RNAIBA 01/2022 - 12/2013
6	Neutralizing AntibodiesIBA 11/2021 - 02/2010
6	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2015
6	Estrogens (Estrogen)FDA Link 01/2021 - 01/2009
6	AntioxidantsIBA 12/2020 - 06/2010
6	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 03/2010
6	AntigensIBA 01/2018 - 08/2007
5	LipidsIBA 01/2022 - 08/2015
5	UbiquitinIBA 01/2022 - 12/2007
5	Thyroid HormonesIBA 01/2022 - 01/2017
5	GP 4 (GP4)IBA 01/2021 - 08/2014
5	Estrogen ReceptorsIBA 01/2021 - 01/2009
5	Carrier Proteins (Binding Protein)IBA 12/2020 - 01/2014
5	Interleukin-8 (Interleukin 8)IBA 01/2020 - 02/2002
5	Small Interfering RNA (siRNA)IBA 01/2020 - 12/2008
5	Indicators and Reagents (Reagents)IBA 07/2018 - 11/2013
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 03/2008
5	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 07/2002
4	AndrogensIBA 10/2022 - 12/2004
4	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2020
4	Angiotensin-Converting Enzyme 2IBA 03/2022 - 04/2015
4	LipopolysaccharidesIBA 03/2022 - 04/2015
4	ProteomeIBA 01/2022 - 03/2004
4	Sirolimus (Rapamycin)FDA Link 01/2022 - 11/2015
4	6-methyladenineIBA 01/2022 - 01/2020
4	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 01/2014
4	Glycoproteins (Glycoprotein)IBA 01/2022 - 01/2012
4	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2022 - 01/2019

Therapy/Procedure

65	Therapeutics 10/2022 - 07/2004
23	Prostatectomy (Retropubic Prostatectomy) 08/2020 - 02/2004
19	Drug Therapy (Chemotherapy) 01/2021 - 09/2007
13	Immunotherapy 04/2022 - 01/2009
11	Hematopoietic Stem Cell Transplantation 12/2022 - 07/2017
9	Nephrectomy 02/2019 - 08/2007
8	Transplantation 12/2022 - 01/2017
5	Radiotherapy 01/2020 - 10/2002